ConductScience.org, home

Paper33906641

Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review.

Liu C and 2 others. Cancer Cell Int, 2021. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review. Papers, record 33906641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33906641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review.
PubMed
Journal
Cancer Cell Int
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
4.66
iCite
Revised in PubMed
2021-05-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu CChanghttps://orcid.org/0000-0002-1397-0124
2Seeram NPNavindra P
3Ma HHang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References117

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123243584Targeting PD-1/PD-L1 interactions for cancer immunotherapy.Oncoimmunology2012https://conductscience.org/library/papers/23243584PubMed
215794662Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor.Biochemistry2005https://conductscience.org/library/papers/15794662PubMed
320373055High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation.Med Oncol2011https://conductscience.org/library/papers/20373055PubMed
432698317Monoclonal Antibodies in Cancer Therapy.Antibodies (Basel)2020https://conductscience.org/library/papers/32698317PubMed
532375257Kaempferol and Its Glycoside, Kaempferol 7-O-Rhamnoside, Inhibit PD-1/PD-L1 Interaction In Vitro.Int J Mol Sci2020https://conductscience.org/library/papers/32375257PubMed
625524383Current advances in T-cell-based cancer immunotherapy.Immunotherapy2014https://conductscience.org/library/papers/25524383PubMed
730107136A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018).Expert Opin Ther Pat2018https://conductscience.org/library/papers/30107136PubMed
832185706Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.Adv Exp Med Biol2020https://conductscience.org/library/papers/32185706PubMed
928881701PD1 signal transduction pathways in T cells.Oncotarget2017https://conductscience.org/library/papers/28881701PubMed
1026945088Genetic and Epigenetic Regulation of PD-1 Expression.J Immunol2016https://conductscience.org/library/papers/26945088PubMed
1112407406Cancer immunoediting: from immunosurveillance to tumor escape.Nat Immunol2002https://conductscience.org/library/papers/12407406PubMed
1229208386Cancer, checkpoint inhibitors, and confusion.Lancet Oncol2017https://conductscience.org/library/papers/29208386PubMed
1327269937Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.J Clin Oncol2016https://conductscience.org/library/papers/27269937PubMed
1418173375PD-1 and its ligands in tolerance and immunity.Annu Rev Immunol2008https://conductscience.org/library/papers/18173375PubMed
1530917623Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology.Molecules2019https://conductscience.org/library/papers/30917623PubMed
1632127660Trends in clinical development for PD-1/PD-L1 inhibitors.Nat Rev Drug Discov2020https://conductscience.org/library/papers/32127660PubMed
1733224152Anticancer Effect of Salvia plebeia and Its Active Compound by Improving T-Cell Activity via Blockade of PD-1/PD-L1 Interaction in Humanized PD-1 Mouse Model.Front Immunol2020https://conductscience.org/library/papers/33224152PubMed
1831151293Development of the Inhibitors that Target the PD-1/PD-L1 Interaction-A Brief Look at Progress on Small Molecules, Peptides and Macrocycles.Molecules2019https://conductscience.org/library/papers/31151293PubMed
1930068796Macrocyclic Compounds from Ansamycin Antibiotic Class as Inhibitors of PD1-PDL1 Protein-Protein Interaction.Chem Pharm Bull (Tokyo)2018https://conductscience.org/library/papers/30068796PubMed
2019258005Development of a homogeneous immunoassay for the detection of angiotensin I in plasma using AlphaLISA acceptor beads technology.Anal Biochem2009https://conductscience.org/library/papers/19258005PubMed

See all 117 referencesDownload CSV of references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42797484Integrated Machine Learning and Molecular Simulation-Guided Discovery of Novel Small-Molecule PD-L1 Inhibitors.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797484PubMed
42741629Multiscale Explainable Machine Learning Reveals Descriptor-Invariant Molecular Determinants of Small-Molecule PD-1/PD-L1 Inhibition.ACS Med Chem Lett2026https://conductscience.org/library/papers/42741629PubMed
42649276A general strategy towards multicolour fluorogenic peptides for wash-free bioassays.Nat Chem2026https://conductscience.org/library/papers/42649276PubMed
42646619A Small Natural Molecule Targeting IL-23/IL-17 Axis Exerts Dual Effects on T-Cell Function and Breast Cancer Cell Migration.Med Sci (Basel)2026https://conductscience.org/library/papers/42646619PubMed
42388631Tumor microenvironment conversion through intelligent nanomedicine: a paradigm shift in overcoming chemoresistance.Front Oncol2026https://conductscience.org/library/papers/42388631PubMed
42248963In silico screen identifies Pranidipine as a potential inhibitor of the PD-1/PD-L1 immune checkpoint.Sci Rep2026https://conductscience.org/library/papers/42248963PubMed
42018553In search of novel PD1 inhibitor from natural products by high-throughput virtual screening and molecular dynamics simulation.PLoS One2026https://conductscience.org/library/papers/42018553PubMed
41850740Intratumoral PD-1-directed IL-2 expression via oncolytic vaccinia virus elicits superior antitumor effects with enhanced safety.J Immunother Cancer2026https://conductscience.org/library/papers/41850740PubMed
41765960KCTD1 stabilizes c-Myc to upregulate PD-L1 and suppress anti-tumor immunity in hepatocellular carcinoma.Cell Death Discov2026https://conductscience.org/library/papers/41765960PubMed
41593769Paroxetine repurposing enhances antitumor immunity via SPOP-mediated PD-L1 ubiquitination and proteasomal degradation.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/41593769PubMed
41333481Mechanisms of immunotherapy in cutaneous squamous cell carcinoma in the tumor microenvironment.Front Immunol2025https://conductscience.org/library/papers/41333481PubMed
41051039Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer Immunotherapy.Anticancer Agents Med Chem2026https://conductscience.org/library/papers/41051039PubMed
40944777Targeting tumor immune evasion: the role of PD-L1 siRNA in advancing cancer immunotherapy.Med Oncol2025https://conductscience.org/library/papers/40944777PubMed
40791660Targeted protein degradation with small molecules for cancer immunotherapy.Asian J Pharm Sci2025https://conductscience.org/library/papers/40791660PubMed
40106025Investigation the immunotherapeutic potential of miR-4477a targeting PD-1/PD-L1 in breast cancer cell line using a CD8+ co-culture model.Mol Biol Rep2025https://conductscience.org/library/papers/40106025PubMed
40075112Activin A affects colorectal cancer progression and immunomodulation in a stage dependent manner.Sci Rep2025https://conductscience.org/library/papers/40075112PubMed
40005217A Comparative Molecular Dynamics Study of Food-Derived Compounds as PD-L1 Inhibitors: Insights Across Six Flavonoid Subgroups.Molecules2025https://conductscience.org/library/papers/40005217PubMed
39696327Metabolizable alloy clusters assemble nanoinhibitor for enhanced radiotherapy of tumor by hypoxia alleviation and intracellular PD-L1 restraint.J Nanobiotechnology2024https://conductscience.org/library/papers/39696327PubMed
39455819Sinulariapeptide F, a new peptide from culture broth of marine-derived fungus Simplicillium sp. SCSIO 41222.J Antibiot (Tokyo)2025https://conductscience.org/library/papers/39455819PubMed
39413175Small molecules from antibody pharmacophores (SMAbPs) as a hit identification workflow for immune checkpoints.Sci Adv2024https://conductscience.org/library/papers/39413175PubMed

See all 46 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33906641

GET https://conductscience.org/api/papers/v1/33906641/references?page=2